Improving Processes of Cancer Care Delivery at a Comprehensive Cancer Center
Mapping the Processes of Cancer Care Delivery at a Comprehensive Cancer Center
2 other identifiers
observational
200
1 country
1
Brief Summary
This study examines how cancer care is delivered in oncology and supportive care clinics. Collecting patient feedback may help doctors better understand the processes of cancer care in oncology and supportive care clinics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2027
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 12, 2021
CompletedFirst Posted
Study publicly available on registry
October 27, 2021
CompletedStudy Start
First participant enrolled
January 30, 2027
ExpectedPrimary Completion
Last participant's last visit for primary outcome
February 2, 2027
Study Completion
Last participant's last visit for all outcomes
February 2, 2027
September 11, 2026
September 1, 2026
3 days
October 12, 2021
September 9, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Minutes spent in discussion
Will be examined using linear mixed models (LMMs) with physician as the unit of analysis.
through study completion, an average of 1 year
Study Arms (1)
Supportive Care (questionnaire, clinic conversation)
Patients complete questionnaires over 15-20 minutes and undergo audio recording of clinic conversations between the oncology team or the specialist palliative care team. Patients' medical records are also reviewed.
Interventions
Undergo audio recording of clinic conversations
Review of medical records
Complete questionnaires
Eligibility Criteria
Patients within 6 months of diagnosis of metastatic (or stage IV) solid malignancies
You may qualify if:
- Within 6 months of diagnosis of metastatic (or stage IV) solid malignancies
- Age 18 or greater
- English speaking
- Follow-up clinic visit (Supportive Care and Medical Oncology Outpatient Clinics at MD Anderson Cancer Center)
- Medical oncologist listed as the attending physician
- COHORT A (Oncology team only cohort): Patients should not have been referred to palliative care services at MD Anderson Cancer Center
- COHORT B (Oncology team and specialist palliative care cohort): Patients should have an upcoming specialist palliative care follow-up visit within 1 week of a medical oncology visit
You may not qualify if:
- Delirium (Memorial Delirium Assessment Scale \[MDAS\] \>= 13/30)
- Significant hearing impairment requiring multiple repetitions during the screening process (that may prolong clinic time)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- M.D. Anderson Cancer Centerlead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Hui
M.D. Anderson Cancer Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 12, 2021
First Posted
October 27, 2021
Study Start (Estimated)
January 30, 2027
Primary Completion (Estimated)
February 2, 2027
Study Completion (Estimated)
February 2, 2027
Last Updated
September 11, 2026
Record last verified: 2026-09